Science Explorer Back to mapMap
Discussion
Topic · Physiology

Sarcoidosis and Beryllium Toxicity Research

Sarcoidosis and Beryllium Toxicity Research is a research topic within Physiology. Science Explorer counts 19k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the clinical characteristics, diagnosis, management, and genetic susceptibility of sarcoidosis, with a specific emphasis on cardiac, pulmonary, and neurosarcoidosis. It also covers the use of various imaging techniques and therapeutic interventions in the context of sarcoidosis.

  • Sarcoidosis
  • Cardiac
  • Diagnosis
  • Management
  • Pulmonary
  • Neurosarcoidosis
  • Granulomatous Inflammation
  • Genetic Susceptibility
  • Imaging
  • Therapy
Research works
19k
fractional, since 1950
In the world top 10%
1.9k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+16%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Sarcoidosis and Beryllium Toxicity Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Sarcoidosis and Beryllium Toxicity Research research?

By volume, the United States and Japan publish the most (1.2k and 303 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.2k works
  2. 2 Japan 303 works
  3. 3 India 280 works
  4. 4 China 262 works
  5. 5 United Kingdom 190 works
  6. 6 France 158 works
  7. 7 Germany 158 works
  8. 8 Italy 155 works
  9. 9 Türkiye 127 works
  10. 10 Spain 126 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.1%Japan: 10.1%India: 9.4%China: 8.8%6 others listed: 30.6%41%largest
United States1,228 · 41.1%Japan303 · 10.1%India280 · 9.4%China262 · 8.8%6 others listed915 · 30.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Sarcoidosis and Beryllium Toxicity Research research?

By volume in 2022-now, Mayo Clinic publishes the most Sarcoidosis and Beryllium Toxicity Research research, followed by All India Institute of Medical Sciences and Johns Hopkins University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 48 works
  2. 2 All India Institute of Medical SciencesIndia 37 works
  3. 3 Johns Hopkins UniversityUnited States 31 works
  4. 4 Harvard UniversityUnited States 30 works
  5. 5 Cleveland ClinicUnited States 30 works
  6. 6 University of PennsylvaniaUnited States 16 works
  7. 7 Université Paris CitéFrance 16 works
  8. 8 Yale UniversityUnited States 16 works
  9. 9 Assistance Publique – Hôpitaux de ParisFrance 16 works
  10. 10 Temple UniversityUnited States 16 works

Who are the leading researchers in Sarcoidosis and Beryllium Toxicity Research?

The most-cited researchers publishing on Sarcoidosis and Beryllium Toxicity Research include Jost Bruno Jonas, Victoria Delgado and Jean‐Louis Vincent.

  1. 1 Jost Bruno Jonas Germany 350k citations
  2. 2 Victoria Delgado Netherlands 269k citations
  3. 3 Jean‐Louis Vincent Belgium 262k citations
  4. 4 Valentı́n Fuster United States 257k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Sarcoidosis and Beryllium Toxicity Research?

The most cited paper in Sarcoidosis and Beryllium Toxicity Research is "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides" (J. Charles Jennette et al., 2012), with 6,681 citations. Next come "Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop" (4,424) and "Idiopathic pulmonary fibrosis" (2,068).

Most cited papers
#PaperReleasedCitations
1 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Charles Jennette et al. · Arthritis & Rheumatism Open access 8 Oct 2012 6,681
2 Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop Douglas A. Jabs, Robert Burton Nussenblatt, James Todd Rosenbaum · American Journal of Ophthalmology Open access 19 Jul 2005 4,424
3 Idiopathic pulmonary fibrosis Luca Richeldi, Harold R. Collard, Mark G. Jones · The Lancet 30 Mar 2017 2,068
4 Sarcoidosis Michael C. Iannuzzi, Benjamin A. Rybicki, Alvin S. Teirstein · New England Journal of Medicine 21 Nov 2007 1,973
5 The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis Randi Y. Leavitt, Anthony S. Fauci, Daniel A. Bloch et al. · Arthritis & Rheumatism Aug 1990 1,964
All 99 most cited papers, with filters and sorting

Where is Sarcoidosis and Beryllium Toxicity Research research done?

The largest centres of Sarcoidosis and Beryllium Toxicity Research research in 2022-now are London (United Kingdom), Tokyo (Japan), New York (United States) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Casablanca and Tunis.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 81 works
  2. 2 TokyoJapan 65 works
  3. 3 New YorkUnited States 60 works
  4. 4 BeijingChina 55 works
  5. 5 ParisFrance 53 works
  6. 6 MoscowRussia 49 works
  7. 7 IstanbulTürkiye 47 works
  8. 8 PhiladelphiaUnited States 44 works
  9. 9 New DelhiIndia 43 works
  10. 10 ClevelandUnited States 40 works

Where it is the local speciality

  1. CasablancaMA · 22.2 works11×
  2. TunisTN · 28.0 works10×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Sarcoidosis and Beryllium Toxicity Research than the world average.

See Sarcoidosis and Beryllium Toxicity Research on the map

Where is the best place to study Sarcoidosis and Beryllium Toxicity Research?

Among universities, judged by research, Johns Hopkins University, Imperial College London and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 22.16%fractional works in this field (log) →share of work in the world top 10% →Imperial College Lon…Erasmus University R…Harvard UniversityJohns Hopkins Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Johns Hopkins UniversityUnited States 72.318.1%5.5×31 +105.6%
2Imperial College LondonUnited Kingdom 65.035.4%3.4×12 +60.6%
3Harvard UniversityUnited States 58.118.2%2.6×30 -11.0%
4Erasmus University RotterdamNetherlands 56.831.7%4.3×8 -3.7%
5Karolinska InstitutetSweden 54.725.4%4.9×10 -36.1%
6All India Institute of Medical SciencesIndia 53.55.9%9.2×37 +98.2%
7Universitat de BarcelonaSpain 52.924.1%4.7×13 +4.4%
8University of Colorado DenverUnited States 52.517.7%11.0×13 -2.6%
9University of CincinnatiUnited States 52.221.7%6.2×14 -11.2%
10King's College LondonUnited Kingdom 50.623.4%3.7×12 +57.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Sarcoidosis and Beryllium Toxicity Research, country by country

Is Sarcoidosis and Beryllium Toxicity Research research growing?

Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Sarcoidosis and Beryllium Toxicity Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sarcoidosis and Beryllium Toxicity Research as a percentage of every work published that year, 0.018% in 2024.

still counting0.010%0.020%0.030%Sarcoidosis and Beryllium Toxicity Research0.017% in 202519801990200020102020

Fractional works of Sarcoidosis and Beryllium Toxicity Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Sarcoidosis and Beryllium Toxicity Research10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Sarcoidosis and Beryllium Toxicity Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.